Volume 74, Issue 1, Pages (July 2018)

Slides:

Advertisements

Similar presentations

Comparison of Outcomes between Brachytherapy and Intensity Modulated Radiotherapy in High Risk Prostate Cancer M. A. Weller, C. A. Reddy, J. Kittel, K.

Advertisements

Volume 62, Issue 3, Pages (September 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 4, Pages (October 2010)

Testosterone Therapy in Men With Prostate Cancer

Volume 63, Issue 5, Pages (May 2013)

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 61, Issue 6, Pages (June 2012)

Volume 60, Issue 5, Pages (November 2011)

Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic.

Volume 70, Issue 4, Pages (October 2016)

Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Volume 69, Issue 1, Pages (January 2016)

Volume 69, Issue 1, Pages (January 2016)

Volume 60, Issue 6, Pages (December 2011)

Volume 70, Issue 2, Pages (August 2016)

Volume 71, Issue 5, Pages (May 2017)

Hormone Therapy for Prostate Cancer: Exploring Current Controversies

Prostate Cancer Epidemic in Sight?

Volume 62, Issue 6, Pages (December 2012)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 68, Issue 4, Pages (October 2015)

Volume 74, Issue 4, Pages (October 2018)

Volume 71, Issue 1, Pages 1-3 (January 2017)

Volume 61, Issue 4, Pages (April 2012)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 67, Issue 6, Pages (June 2015)

Volume 73, Issue 6, Pages (June 2018)

Volume 71, Issue 5, Pages (May 2017)

Volume 57, Issue 4, Pages e41-e42 (April 2010)

Volume 71, Issue 6, Pages (June 2017)

Laurent Boccon-Gibod European Urology Supplements

Volume 64, Issue 6, Pages (December 2013)

Prostate Cancer Epidemic in Sight?

Volume 71, Issue 6, Pages (June 2017)

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

11C-Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate Cancer I.J de Jong, J Pruim, P.H Elsinga, W Vaalburg,

Volume 61, Issue 6, Pages (June 2012)

Volume 53, Issue 6, Pages (June 2008)

Volume 74, Issue 2, Pages (August 2018)

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

Volume 66, Issue 2, Pages (August 2014)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 71, Issue 1, Pages (January 2017)

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Volume 73, Issue 2, Pages (February 2018)

Skeletal Morbidity in Men with Prostate Cancer: Quality-of-Life Considerations throughout the Continuum of Care Fred Saad, Carl Olsson, Claude C. Schulman

Volume 70, Issue 2, Pages (August 2016)

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer– specific Mortality: Competition Between Age and Time to Biochemical Failure

Volume 71, Issue 5, Pages (May 2017)

Testicular Cancer Variations in Time and Space in Europe

Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer Amar U. Kishan, Rahul.

Volume 72, Issue 2, Pages (August 2017)

European Urology is “Your” Journal

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results.

Improving Flexibility and Quality of Life for Your Patients: A Must?

Volume 53, Issue 6, Pages (June 2008)

Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis Sarah Burdett, Liselotte M. Boevé,

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018 Thomas M. Pisansky, MD, Ian M. Thompson,

Epidemiology and Demographics of Prostatitis

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 74, Issue 1, Pages 99-106 (July 2018) Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer Stephen J. Ramey, Shree Agrawal, Matthew C. Abramowitz, Drew Moghanaki, Thomas M. Pisansky, Jason A. Efstathiou, Jeff M. Michalski, Daniel E. Spratt, Jason W.D. Hearn, Bridget F. Koontz, Stanley L. Liauw, Alan Pollack, Mitchell S. Anscher, Robert B. Den, Kevin L. Stephans, Anthony L. Zietman, W. Robert Lee, Andrew J. Stephenson, Rahul D. Tendulkar European Urology Volume 74, Issue 1, Pages 99-106 (July 2018) DOI: 10.1016/j.eururo.2017.10.009 Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 1 Cumulative incidence of freedom from biochemical failure (FFBF) by treatment for all patients with Gleason score 7–10 disease. ADT=androgen deprivation therapy; SRT=salvage radiation therapy. European Urology 2018 74, 99-106DOI: (10.1016/j.eururo.2017.10.009) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 2 Cumulative incidence of distant metastases (DM) by treatment for all patients with Gleason score 7–10 disease. ADT=androgen deprivation therapy; SRT=salvage radiation therapy. European Urology 2018 74, 99-106DOI: (10.1016/j.eururo.2017.10.009) Copyright © 2017 European Association of Urology Terms and Conditions